<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url><loc>https://gosset.ai/news/2026-11-16/gazyva-wins-kidney-disease-approval-8a2ec720</loc><news:news><news:publication><news:name>Gosset News</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-16T23:00:00Z</news:publication_date><news:title>Gazyva Wins Kidney Disease Approval</news:title></news:news></url>
  <url><loc>https://gosset.ai/news/2026-11-16/fda-approves-perioperative-imfinzi-regimen-981f8d95</loc><news:news><news:publication><news:name>Gosset News</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-16T23:00:00Z</news:publication_date><news:title>FDA Approves Perioperative Imfinzi Regimen</news:title></news:news></url>
  <url><loc>https://gosset.ai/news/2026-11-16/fda-approves-imfinzi-adc-regimen-e7c6eef7</loc><news:news><news:publication><news:name>Gosset News</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-16T23:00:00Z</news:publication_date><news:title>FDA Approves Imfinzi ADC Regimen</news:title></news:news></url>
  <url><loc>https://gosset.ai/news/2026-11-16/china-approves-hengrui-angptl3-antibody-d66686bf</loc><news:news><news:publication><news:name>Gosset News</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-16T23:00:00Z</news:publication_date><news:title>China Approves Hengrui ANGPTL3 Antibody</news:title></news:news></url>
</urlset>
